My Research – Session 2: Adherence Interventions

Session 2 (Wednesday 24th February at 7pm GMT) –  CLICK HERE to REGISTER

 

We would like to invite you to join our monthly ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The second session will be delivered by: Nick Duncan and Andrea Preston

 

Biography (Nick Duncan) – Nick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

 

 

 

 

Biography (Andrea Preston) – Andrea is the Divisional Lead Pharmacist for Haematology at University Hospitals Bristol NHS Foundation Trust and part time Cancer Commissioning Pharmacist for NHSE South. She studied pharmacy at Cardiff University and qualified in 1999. The majority of her career has been in cancer services. In her clinical role she is proud to work within an excellent team of cancer pharmacists delivering specialist pharmacy services to oncology and haematology including BMT and CAR-T. She is an independent prescriber in multiple myeloma and amyloidosis. Her special interest in pharmacy research started after completing an MSc in Clinical Oncology at University of Birmingham, where she met and started collaborating with Nick Duncan. Special areas of research interest include dosing of systemic anticancer therapy (SACT) in obesity, adherence and use of technology to improve safety of SACT.

 

 

 

 

 

 

Please Note:

 

-Webinars will start at 19:00 GMT and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day before the event

-Webinars are FREE to access for BOPA Paid Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this link: https://www.bopa.org.uk/course-category/audit-and-research/

-Webinars will be on a monthly basis

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

 

Latest News

By Clayton Wong on 13th October 2025

Join the Upcoming Pharmacists Webinar: Interactive Case Study on Prevention and Treatment of Fungal Infections in Stem Cell Transplant Patients

  On Thursday 23 October at 16:00 CEST, the EBMT Pharmacist Committee hosts a free webinar on on prevention and treatment of fungal infections in HCT patients. Save your seat…

Read article
By BOPA E&T Subcommittee on 10th October 2025

SAVE THE DATE: BOPA Introduction to Cancer Course, Scotland, March 2026

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By ISOPP & BOPA on 8th October 2025

ISOPP & BOPA Joint Webinar: Sitting in the opposite chair, part of London Global Cancer Week – 2025

The upcoming ISOPP & BOPA joint webinar, Sitting in the opposite chair, part of London Global Cancer Week – 2025, will take place on November 26, 2025 at 7:00 PST…

Read article
By BOPA Executive Committee on 7th October 2025

BOPA 2025 Annual Report NOW Published

BOPA Annual Report 2025 – BOPA Welcome to the 2025 BOPA Annual Report. The last year has been another excellent year for BOPA. As you can see from our report…

Read article